PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33903122-0 2021 EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma. Sorafenib 78-87 EPH receptor B2 Homo sapiens 0-5 33903122-4 2021 RNA-sequencing analysis of sorafenib-resistant PDXs and their corresponding mock controls identified EPHB2 as the most significantly upregulated kinase. Sorafenib 27-36 EPH receptor B2 Homo sapiens 101-106